The shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) started off the last trading session with the price of $2.64 while closing the day with the price of $2.59. The shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) Fell -1.52% with the Loss of -0.05 points.
The shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) traded with the day volume of 1.73 Million shares whereas its average trading volume is 1.15 Million.
While analyzing the past performance of the stock we can see that the shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) Loss -6.83% in the last week while rising 4.86% in the last month. Past quarter performance shows the red light with -5.47%. The semi-annual and annual performance shows -51.77% and -44.78% respectively.
Some critical values of the shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) to be discussed here are: the beta which shows the value at 1.54 while Average True Range of Pacific Biosciences of California, Inc. (NASDAQ:PACB) demonstrate the value at 0.16. The weekly and monthly volatility of the shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) are indicated at 4.67% and 6.13%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 49.91.
While studying the financial position of the shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB), we can see that the Market capitalization of the company is at 343.69 Million. The shares outstanding for the company is 132.7 Million and the shares float stands at 124.27 Million. The income of the company stand at -92200000 while the sales stand at 93.5 Million.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.89, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 3.68, the Return on Asset ROA stood at -0.599 and the Return on Equity ROE depicted at -0.99 while Return on Investment ROI is at -0.901.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) started its previous trading session at $83.88 and closed at $84.1 showing a Rise of 0.63 Percent.
The Company traded with an average Volume of 1.28 Million whereas, its Day Volume stood at 1.73 Million.
Looking at the performance of the stock, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Gain 0.35% in the last week in its shares price and -0.52% in the last month. Quarterly performance shows a red of -5.14 Percent while Semi-Annual and Annual performances shows a -7.82 and -7.54 percent respectively.
Beta for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands at 1.72 while the ATR (average true range) is at 2.53. The Stock’s Weekly and Monthly Volatility is 2.59% and 2.98% respectively showing a RSI value of 49.77.
While studying the financial position of the shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), we can see that the Market capitalization of the company is at 14.76 Billion. The shares outstanding for the company is 175.5 Million and the shares float stands at 174.81 Million.
The Company generated an income of -159300000 and the sales of 1.31 Billion in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.91 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 11.24 respectively.
The Return on Assets stands at -0.027, ROE shows a value of -0.042 and ROI for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is -0.035 as of Trailing Twelve Months period.